202 related articles for article (PubMed ID: 32691938)
1. Combined treatment of palmar hyperhidrosis with botulinum toxin type A and oxybutynin chloride: Results of a clinical, multicenter, prospective study.
Campanati A; Gregoriou S; Consales V; Rizzetto G; Bobyr I; Diotallevi F; Martina E; Kontochristopoulos G; Platsidaki E; Offidani A
Dermatol Ther; 2020 Nov; 33(6):e14039. PubMed ID: 32691938
[TBL] [Abstract][Full Text] [Related]
2. C-Arm Guided Percutaneous Radiofrequency Thoracic Sympathectomy for Treatment of Primary Palmar Hyperhidrosis in Comparison with Local Botulinum Toxin Type A Injection, Randomized Trial.
Mostafa TAH; Hamed AA; Mohammed BM; El Sheikh NA; Shama AAA
Pain Physician; 2019 Nov; 22(6):591-599. PubMed ID: 31775406
[TBL] [Abstract][Full Text] [Related]
3. Oxybutynin gel versus nanoemulgel for treating primary palmar hyperhidrosis: A pilot double-blind randomized controlled trial.
Saki N; Shakouri N; Rastaghi F; Hosseini SA; Alipour S; Ahramiyanpour N
J Cosmet Dermatol; 2023 Aug; 22(8):2268-2272. PubMed ID: 36999480
[TBL] [Abstract][Full Text] [Related]
4. Oxybutynin as a treatment for generalized hyperhidrosis: a randomized, placebo-controlled trial.
Schollhammer M; Brenaut E; Menard-Andivot N; Pillette-Delarue M; Zagnoli A; Chassain-Le Lay M; Sassolas B; Jouan N; Le Ru Y; Abasq-Thomas C; Greco M; Penven K; Roguedas-Contios AM; Dupré-Goetghebeur D; Gouedard C; Misery L; Le Gal G
Br J Dermatol; 2015 Nov; 173(5):1163-8. PubMed ID: 26114588
[TBL] [Abstract][Full Text] [Related]
5. [Use of oral oxybutynin at 7.5 mg per day in primary hyperhidrosis].
Try C; Messikh R; Elkhyat A; Aubin F; Humbert RP
Rev Med Liege; 2012 Oct; 67(10):520-6. PubMed ID: 23167161
[TBL] [Abstract][Full Text] [Related]
6. Treatment of generalized hyperhidrosis with oxybutynin in post-menopausal patients.
Kim WO; Kil HK; Yoon KB; Yoo JH
Acta Derm Venereol; 2010 May; 90(3):291-3. PubMed ID: 20526549
[TBL] [Abstract][Full Text] [Related]
7. Oxybutynin in primary hyperhidrosis: A long-term real-life study.
Almeida ART; Ferrari F; Restrepo MVS; Rocha VB
Dermatol Ther; 2020 Nov; 33(6):e14344. PubMed ID: 32981151
[TBL] [Abstract][Full Text] [Related]
8. Efficacy, Safety and Quality of Life of Oxybutynin versus Aluminum Chloride Hexahydrate in Treating Primary Palmar Hyperhidrosis.
Attallah HS; El-Gilany AH; Youssef YEB; Abdelshaheed ME; Sharaf EFA
Indian J Dermatol; 2022; 67(3):222-227. PubMed ID: 36386101
[TBL] [Abstract][Full Text] [Related]
9. Safety and prolonged efficacy of Botulin Toxin A in primary hyperhidrosis.
D'Epiro S; Macaluso L; Salvi M; Luci C; Mattozzi C; Marzocca F; Salvo V; Scarnò M; Calvieri S; Richetta AG
Clin Ter; 2014; 165(6):e395-400. PubMed ID: 25524193
[TBL] [Abstract][Full Text] [Related]
10. CT-Guided Chemical Thoracic Sympathectomy versus Botulinum Toxin Type A Injection for Palmar Hyperhidrosis.
Yang H; Kang J; Zhang S; Peng K; Deng B; Cheng B
Thorac Cardiovasc Surg; 2019 Aug; 67(5):402-406. PubMed ID: 30216949
[TBL] [Abstract][Full Text] [Related]
11. A novel lotion formulation of 20% oxybutynin hydrochloride for the treatment of primary palmar hyperhidrosis: A randomized, placebo-controlled, double-blind, phase III study.
Fujimoto T; Terahara T; Okawa K; Inakura H; Hirayama Y; Yokozeki H
J Am Acad Dermatol; 2023 Jul; 89(1):62-69. PubMed ID: 36990320
[TBL] [Abstract][Full Text] [Related]
12. Muscle weakness in treatment of palmar hyperhidrosis with botulinum toxin type a: can it be prevented?
Kouris A; Vavouli C; Markantoni V; Kontochristopoulos G
J Drugs Dermatol; 2014 Nov; 13(11):1315-6. PubMed ID: 25607695
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Assessment of Facial Hyperhidrosis Management: Evaluating the Utility and Quality of Life Improvements following Botulinum Toxin Injection.
Prodan-Barbulescu C; Castiglione L; Burtic SR; Murariu M; Reddy S; Rosca O; Bratosin F; Melania Fizedean C; Krupyshev P; Enatescu I
Toxins (Basel); 2024 Jan; 16(1):. PubMed ID: 38276535
[TBL] [Abstract][Full Text] [Related]
14. Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival.
Campanati A; Sandroni L; Gesuita R; Giuliano A; Giuliodori K; Marconi B; Ganzetti G; Offidani A
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):917-21. PubMed ID: 21054569
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
Rosell K; Hymnelius K; Swartling C
Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of botulinum toxin type A local injection therapy for head and forehead hyperhidrosis.
Ando Y; Ohshima Y; Yanagishita T; Watanabe H; Tamada Y; Akiyama M; Watanabe D
J Dermatol; 2022 Jul; 49(7):719-723. PubMed ID: 35393718
[TBL] [Abstract][Full Text] [Related]
17. Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: results of an open-label study.
Campanati A; Penna L; Guzzo T; Menotta L; Silvestri B; Lagalla G; Gesuita R; Offidani A
Clin Ther; 2003 Jan; 25(1):298-308. PubMed ID: 12637128
[TBL] [Abstract][Full Text] [Related]
18. A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis.
Wolosker N; de Campos JR; Kauffman P; Puech-Leão P
J Vasc Surg; 2012 Jun; 55(6):1696-700. PubMed ID: 22341836
[TBL] [Abstract][Full Text] [Related]
19. Topical Oxybutynin 3% Gel Versus Aluminum Chloride 15% Lotion in Treatment of Primary Focal Hyperhidrosis.
El-Agamy El-Samadony A; Hegab DS; El Maghraby GM; El-Maadawy IH
Dermatol Pract Concept; 2023 Jul; 13(3):. PubMed ID: 37557105
[TBL] [Abstract][Full Text] [Related]
20. Botulinum A toxin improves life quality in severe primary focal hyperhidrosis.
Swartling C; Naver H; Lindberg M
Eur J Neurol; 2001 May; 8(3):247-52. PubMed ID: 11328333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
